Effectiveness of single-session therapy for adult common mental disorders: a systematic review.
Adult
Common mental disorder
Single-session therapy
Systematic review
Treatment gap
Journal
BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676
Informations de publication
Date de publication:
07 Nov 2023
07 Nov 2023
Historique:
received:
04
06
2023
accepted:
25
10
2023
medline:
9
11
2023
pubmed:
8
11
2023
entrez:
8
11
2023
Statut:
epublish
Résumé
Common mental disorders (CMDs) impose significant socioeconomic impacts on the global community. Nevertheless, over 50% of individuals with CMDs do not receive proper treatment, indicating that the current treatment modalities do not adequately tackle this issue. Since single-session therapy (SST) is a potential method for reducing the treatment gap, it is crucial to evaluate its effectiveness. Therefore, this systematic review aimed to evaluate the effectiveness of SST on CMD symptoms in adults. This systematic review included randomised and non-randomised studies assessing the clinical effectiveness of SST on CMD symptoms in adults. English-written, peer-reviewed studies or dissertations were included, while grey literature was excluded. MEDLINE, Embase, PsycINFO, and Cochrane's CENTRAL were searched on December 13, 2022, from their inception dates. The risk of bias in the included studies was evaluated using RoB 2 and ROBINS-I. A narrative synthesis was performed. This systematic review was registered in the PROSPERO database on July 6, 2022 (CRD42022343925). Six randomised and three non-randomised studies were included after screening 2,130 records. Three non-randomised studies with a "critical" or "serious" risk of bias were excluded from the synthesis. Therefore, six randomised trials involving 298 participants were included in the synthesis. Four out of six studies had a "high" risk of bias. The participants had non-severe symptoms at baseline, and three intervention types (behavioural activation, DBT, and solution-focused psychotherapy) were evaluated. Five of six studies showed positive results for depression, with only one reporting a positive result for anxiety. SST may be effective in improving CMD symptoms in adults, particularly depression. However, there is a limit to deriving definite conclusions due to a high risk of bias in included studies, insufficient sample size and research volume. Further research exploring the characteristics of clients who can benefit from SST is required to facilitate its widespread use.
Sections du résumé
BACKGROUND
BACKGROUND
Common mental disorders (CMDs) impose significant socioeconomic impacts on the global community. Nevertheless, over 50% of individuals with CMDs do not receive proper treatment, indicating that the current treatment modalities do not adequately tackle this issue. Since single-session therapy (SST) is a potential method for reducing the treatment gap, it is crucial to evaluate its effectiveness. Therefore, this systematic review aimed to evaluate the effectiveness of SST on CMD symptoms in adults.
METHODS
METHODS
This systematic review included randomised and non-randomised studies assessing the clinical effectiveness of SST on CMD symptoms in adults. English-written, peer-reviewed studies or dissertations were included, while grey literature was excluded. MEDLINE, Embase, PsycINFO, and Cochrane's CENTRAL were searched on December 13, 2022, from their inception dates. The risk of bias in the included studies was evaluated using RoB 2 and ROBINS-I. A narrative synthesis was performed. This systematic review was registered in the PROSPERO database on July 6, 2022 (CRD42022343925).
RESULTS
RESULTS
Six randomised and three non-randomised studies were included after screening 2,130 records. Three non-randomised studies with a "critical" or "serious" risk of bias were excluded from the synthesis. Therefore, six randomised trials involving 298 participants were included in the synthesis. Four out of six studies had a "high" risk of bias. The participants had non-severe symptoms at baseline, and three intervention types (behavioural activation, DBT, and solution-focused psychotherapy) were evaluated. Five of six studies showed positive results for depression, with only one reporting a positive result for anxiety.
CONCLUSIONS
CONCLUSIONS
SST may be effective in improving CMD symptoms in adults, particularly depression. However, there is a limit to deriving definite conclusions due to a high risk of bias in included studies, insufficient sample size and research volume. Further research exploring the characteristics of clients who can benefit from SST is required to facilitate its widespread use.
Identifiants
pubmed: 37936186
doi: 10.1186/s40359-023-01410-0
pii: 10.1186/s40359-023-01410-0
pmc: PMC10631081
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
373Informations de copyright
© 2023. The Author(s).
Références
Behav Res Ther. 2014 May;56:60-7
pubmed: 24685536
Br J Psychiatry. 2008 Jan;192(1):52-8
pubmed: 18174510
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Annu Rev Psychol. 2013;64:135-68
pubmed: 23020641
Cochrane Database Syst Rev. 2021 Aug 5;8:CD009149
pubmed: 34352116
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Front Psychol. 2021 Sep 01;12:721382
pubmed: 34539523
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Lancet. 2007 Sep 8;370(9590):878-89
pubmed: 17804062
Psychol Med. 1992 Nov;22(4):1011-8
pubmed: 1488473
Psychol Med. 1998 Jan;28(1):145-52
pubmed: 9483690
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Br J Psychiatry. 2001 Sep;179:191-3
pubmed: 11532793
Trials. 2008 Jan 25;9:4
pubmed: 18221516
Bull World Health Organ. 2004 Nov;82(11):858-66
pubmed: 15640922
Suicide Life Threat Behav. 2013 Jun;43(3):324-35
pubmed: 23409778
Int J Geriatr Psychiatry. 2003 Jun;18(6):479-85
pubmed: 12789667
J Clin Child Adolesc Psychol. 2020 Mar-Apr;49(2):264-278
pubmed: 31799863
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
World Psychiatry. 2021 Oct;20(3):387-396
pubmed: 34505365
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S467-72
pubmed: 22588767
J Affect Disord. 2017 Nov;222:153-161
pubmed: 28709022
Lancet Psychiatry. 2022 Feb;9(2):137-150
pubmed: 35026139
BMC Public Health. 2020 Sep 29;20(1):1470
pubmed: 32993605
Behav Cogn Psychother. 2017 Jan;45(1):58-72
pubmed: 27692021
J Nerv Ment Dis. 2010 Nov;198(11):783-9
pubmed: 21048467
J Affect Disord. 2021 Jan 15;279:208-216
pubmed: 33059224
J Clin Psychol. 1984 Mar;40(2):475-80
pubmed: 6725568
J Am Acad Child Adolesc Psychiatry. 2017 Feb;56(2):107-115
pubmed: 28117056
Australas Psychiatry. 2019 Feb;27(1):21-24
pubmed: 30488715
Lancet Glob Health. 2020 Nov;8(11):e1352
pubmed: 33069297
J Ment Health. 2013 Feb;22(1):60-71
pubmed: 23343048
Br J Psychiatry. 2022 Sep;221(3):553-557
pubmed: 35137680
J Ment Health. 2016 Oct;25(5):403-409
pubmed: 26667144
Neurosci Lett. 2013 May 24;543:42-6
pubmed: 23562516
J Pharmacol Pharmacother. 2010 Jul;1(2):100-7
pubmed: 21350618